ADAR1 Capital Management »

Protara Therapeutic shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Protara Therapeutic (TARA) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Protara Therapeutic

Tip: Access up to 7 years of quarterly data

All positions including Protara Therapeutic held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protara Therapeutic by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $8.0k 2.0k 4.01
2023-12-31 $4.1k 2.2k 1.88

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Protara Therapeutic

RA Capital Management
Opaleye Management
Stempoint Capital
Woodline Partners
Boxer Capital
Citadel Advisors
Baker Bros. Advisors
Armistice Capital
Vanguard Group
Renaissance Technologies
CVI Holdings
Oppenheimer & Co
Geode Capital Management
Two Sigma Investments
Ikarian Capital

View all funds holding Protara Therapeutic